Stay updated on Finerenone and Empagliflozin Combination in CKD Clinical Trial
Sign up to get notified when there's something new on the Finerenone and Empagliflozin Combination in CKD Clinical Trial page.

Latest updates to the Finerenone and Empagliflozin Combination in CKD Clinical Trial page
- Check4 days agoChange DetectedThis update shows the study is no longer recruiting and updates the record to version v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.2%

- Check11 days agoChange DetectedA new version (Revision: v3.5.5) was returned on 2026-06-02. It adds sections for Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and other related information, along with a QC status indicator and updated navigation items.SummaryDifference0.8%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry v3.5.4 is added to the record history, replacing the previous v3.5.3. This reflects an updated version of the study record in the history timeline.SummaryDifference0.1%

- Check40 days agoChange DetectedThe References entry was removed from a version in the Study Record History, reducing visibility of sources cited for that version. The rest of the version details remain unchanged.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor technical release with no visible change to the study record history content.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.1%

Stay in the know with updates to Finerenone and Empagliflozin Combination in CKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone and Empagliflozin Combination in CKD Clinical Trial page.